By Deena Beasley (Reuters) – Merck Co Inc said on Sunday it has submitted an application to the U.S. Food and Drug Administration for its drug Keytruda as a treatment for advanced non-small cell lung cancer, the most common form of the disease. Keytruda, a…
Source:Merck files for FDA approval of Keytruda in lung cancer
Sunday, April 19, 2015
Merck files for FDA approval of Keytruda in lung cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment